ASD and Genetic Associations with Receptors for Oxytocin and Vasopressin—AVPR1A, AVPR1B, and OXTR by Sunday M. Francis et al.
ORIGINAL RESEARCH
published: 22 November 2016
doi: 10.3389/fnins.2016.00516
Frontiers in Neuroscience | www.frontiersin.org 1 November 2016 | Volume 10 | Article 516
Edited by:
John Vijay Sagar Kommu,
National Institute of Mental Health and
Neurosciences, India
Reviewed by:
Blythe A. Corbett,
Vanderbilt University, USA
Richard Paul Ebstein,
National University of Singapore,
Singapore
*Correspondence:
Suma Jacob
sjacob@umn.edu
Specialty section:
This article was submitted to
Child and Adolescent Psychiatry,
a section of the journal
Frontiers in Neuroscience
Received: 10 May 2016
Accepted: 26 October 2016
Published: 22 November 2016
Citation:
Francis SM, Kim S-J, Kistner-Griffin E,
Guter S, Cook EH and Jacob S (2016)
ASD and Genetic Associations with
Receptors for Oxytocin and
Vasopressin—AVPR1A, AVPR1B, and
OXTR. Front. Neurosci. 10:516.
doi: 10.3389/fnins.2016.00516
ASD and Genetic Associations with
Receptors for Oxytocin and
Vasopressin—AVPR1A, AVPR1B, and
OXTR
Sunday M. Francis 1, Soo-Jeong Kim 2, Emily Kistner-Griffin 3, Stephen Guter 4,
Edwin H. Cook 4 and Suma Jacob 1*
1Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA, 2Department of Psychiatry and Behavioral
Sciences, University of Washington, WA, USA, 3 Biostatistics Shared Resource, Hollings Cancer Center, Medical University of
South Carolina, Charleston, SC, USA, 4Department of Psychiatry, Institute of Juvenile Research, University of Illinois at
Chicago, Chicago, IL, USA
Background: There are limited treatments available for autism spectrum disorder (ASD).
Studies have reported significant associations between the receptor genes of oxytocin
(OT) and vasopressin (AVP) and ASD diagnosis, as well as ASD-related phenotypes.
Researchers have also found the manipulation of these systems affects social and
repetitive behaviors, core characteristics of ASD. Consequently, research involving
the oxytocin/vasopressin pathways as intervention targets has increased. Therefore,
further examination into the relationship between these neuropeptides and ASD was
undertaken. In this study, we examined associations between variants in the receptor
genes of vasopressin (AVPR1A, AVPR1B), oxytocin (OXTR), and ASD diagnosis along
with related subphenotypes.
Methods: Probands were assessed using Autism Diagnostic Interview-Revised, Autism
Diagnostic Observation Schedule, and clinical DSM-IV-TR criteria. Single nucleotide
polymorphisms (SNPs) in AVPR1B and OXTR, and microsatellites in AVPR1A were
genotyped in ∼200 families with a proband with ASD. Family-based association testing
(FBAT) was utilized to determine associations between variants and ASD. Haplotypes
composed of OXTR SNPs (i.e., rs53576-rs2254298-rs2268493) were also analyzed due
to previously published associations.
Results: Using the additive inheritance model in FBAT we found associations
between AVPR1B SNPs (rs28632197, p = 0.005, rs35369693, p = 0.025) and
diagnosis. As in other studies, OXTR rs2268493 (p = 0.050) was associated
with diagnosis. rs2268493 was also associated with ASD subphenotypes of
social withdrawal (p = 0.013) and Insistence on Sameness (p = 0.039). Further
analyses demonstrated that the haplotype, rs2254298–rs2268493 was found to be
significantly associated with diagnosis (A-T; p = 0.026). FBAT was also used to
analyze AVPR1A microsatellites (RS1 and RS3). Both length variants were found
to be associated with restrictive, repetitive behaviors, but not overall diagnosis.
Correction for multiple comparisons was performed for SNPs tested in each gene
region, only AVPR1B SNPs remained significantly associated with ASD diagnosis.
Francis et al. Neuropeptide Receptor Variants in ASD
Conclusions: Autism is a heterogeneous disorder with many genes and pathways
that contribute to its development. SNPs and microsatellites in the receptor genes of
OT and AVP are associated with ASD diagnosis and measures of social behavior as
well as restricted repetitive behaviors. We reported a novel association with ASD and
AVPR1B SNPs. Understanding of genotype-phenotype relationships may be helpful in
the development of pharmacological interventions for the OT/AVP system.
Keywords: neuropeptides, oxytocin, vasopressin, receptors, social behaviors, repetitive behaviors
INTRODUCTION
Autism spectrum disorder (ASD) is a heterogeneous disorder
that is characterized by impaired social communications
and interactions, and restricted, repetitive behaviors (American
Psychiatric Association, 2013). The range of clinical presentations
suggest multiple etiologies which makes searching for
mechanisms and genetic associations challenging. While
many genes and pathways have been associated with ASD, the
close relationship established between the oxytocin (peptide: OT,
gene:OXT) and vasopressin (peptide: AVP, gene:AVP) systems to
social and restricted repetitive behaviors (RRBs) have made these
systems a focal point as investigators work to elucidate potential
pathophysiological mechanisms and treatments pathways for
ASD.
OT and AVP, two closely related neuropeptides, are conserved
in both structure and function across mammalian species.
While the relationship between these neuropeptide systems and
behaviors are complex (Appenrodt et al., 1998; Chang et al.,
2012), in general, OT facilitates prosocial and “approaching”
behaviors, social memory and recognition, and reduction in
anxiety and reaction to stressors (Carter, 1998; Ferguson et al.,
2000; Kosfeld et al., 2005; Seltzer et al., 2010; Neumann
and Landgraf, 2012). AVP has been associated with animal
territoriality and “defensive” behaviors, including sexual cues in
human males, social hierarchy, and anxiogenic effects (Landgraf
andWigger, 2003; Guastella et al., 2011; Van der Kooij and Sandi,
2015). It has been noted while closely related, these systems
can have opposing physiological effects. OT has primarily
parasympathetic actions on the autonomic nervous system, and
AVP induces reactions in the sympathetic nervous system and
hypothalamic-pituitary-adrenal axis (Sawchenko and Swanson,
1985; Kenkel et al., 2012).
The systems also interact with each other: at high levels the
two peptides can act as partial agonists for their homologous
receptors (Chini et al., 1996). In a 2014 study of threat response in
cats, AVP increased anxiety via the vasopressin receptor 1B and
OT increased social affiliation during threat via the vasopressin
receptor 1A (Bowen and McGregor, 2014). The receptors of
OT and AVP have also been implicated in these behaviors
and disorders characterized by impairments in social behaviors
including ASD and related subphenotypes (Kim et al., 2002;
Wassink et al., 2004; Wu et al., 2005; Lerer et al., 2008; Yang
et al., 2010a,b; LoParo and Waldman, 2015). Animal studies
Abbreviations: RRB(s), Restrictive/Repetitive Behavior(s); SNP(s), Single
Nucleotide Polymorphism(s).
which established the involvement of OT and AVP systems in
social and repetitive behaviors as well as genetic associations
between the neuropeptide systems and disorders with social
impairment (i.e., ASD), strengthen the theories to target the
OT and AVP systems in the treatment of disorders with social
impairments.
Investigators have attempted to influence the oxytocinergic
system by directly administering OT. Presently there are over a
hundred clinical trials, including 11 in ASD, utilizing intranasal
OT (INOT) according to clinicaltrials.gov (as of April 25,
2016). In individuals with ASD, INOT has been shown to
increase social interaction (in a simulated ball game task) and
improve the identification of emotions (Andari et al., 2010;
Guastella et al., 2010). The other part of this equation is
the target of OT, the oxytocin receptor (receptor: OTR; gene:
OXTR). Similar to OT, protein expression of OTR has also been
associated with social behaviors including maternal nurturing
(Takayanagi et al., 2005). In animal studies, Takayanagi et al.
(2005) found Oxtr−/− dams had deficits in pup retrieval, a
maternal behavior. In addition, research in the last 20 years
has found links between OXTR and ASD. In a 2005 study,
evidence of transmission disequilibrium of two OXTR single
nucleotide polymorphisms (SNPs; rs2254298 and rs53576) was
observed in a Han Chinese ASD sample (Wu et al., 2005).
These results were followed up by research in other ethnic
populations. Jacob et al. (2007) found an association between
rs2254298, but not rs53576, and ASD in a Caucasian sample.
In a Japanese sample, Liu et al. (2010) observed significant
differences in allelic frequency in rs2254298 between controls
and individuals with ASD. In more recent studies, Skuse et al.
(2014) investigated associations between 60 tagged OXTR SNPs
and social recognition skills in ASD families from the UK
and Finland. They found rs237887 associated with the Face
Recognition Memory Task not only in ASD individuals, but
their mothers, fathers and non-affected siblings as well. They
also noted an association between rs237865 and diagnosis,
but it did not remain after Bonferroni correction. Two recent
meta-analyses (LoParo and Waldman, 2015; Kranz et al., 2016)
reported associations between OXTR and ASD. LoParo and
Waldman (2015) reported associations between ASD and the
OXTR SNPs, rs7632287, rs2268491, and rs2254298 in eight
studies and 11 independent samples; analyzing two independent
samples and 10 additional studies, Kranz et al. (2016) found
rs237889 to be associated with ASD.
Studies exploring the use of intranasally administered AVP
(IN-AVP; or similar compound desmopressin, DDAVP) are
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fewer than INOT, yet the involvement of the AVP system in
mammalian social behavior is also important. As mentioned
before OT can interact with AVP receptors, making AVP
receptors not only a target for AVP and pharmacology that
mimic AVP, but for OT agonists as well. Often researchers have
examined three nucleotide repeats: two located in the 5′ promoter
region (RS1, RS3) and one in the intron (AVR) of AVPR1A. In
both patient and non-patient populations the lengths of these
repeats have been shown to modulate social behaviors including
altruistic behavior in healthy adults, prepulse inhibition, and the
processing of facial expressions (Knafo et al., 2008; Levin et al.,
2009; Zink and Meyer-Lindenberg, 2012; Wang et al., 2016).
In an ASD sample, evidence of disequilibrium of the AVPR1A
microsatellite RS3 was observed in 115 trios (Kim et al., 2002). A
few years later, Wassink et al. (2004) found evidence of linkage
disequilibrium in an ASD sample as well. In 2010, Yang and
colleagues noted an association between ASD and RS1 and RS3
in a Korean sample (Yang et al., 2010b). Tansey et al. (2011)
found a significant association between ASD and AVPR1A SNPs,
but only a weak association with the microsatellites in an Irish
sample.
The role of AVPR1B has been investigated in some disorders,
but not in ASD. Studies have shown that Avpr1b knockout
mice display decreased ultrasonic vocalization in social situations
throughout their lifespans, decreased aggression, and altered
social behavior affiliated with dominance (Scattoni et al., 2008;
Caldwell et al., 2010; Pagani et al., 2015). The relationship
between Avpr1b and aggression was strengthened by the
Pagani et al. (2015) study, which showed the rescue of
aggression by targeted expression of Avpr1b in the hippocampus.
Additionally, Caldwell et al. (2010) observed increased aggression
in Avpr1b−/− mice under specific social conditions including
competition, food deprivation, and social experience. In humans,
SNPs in AVPR1B have been linked to child aggression,
childhood-onset mood disorders (COMD), prosociality, and
autistic traits (Dempster et al., 2007, 2009; Chakrabarti et al.,
2009; Zai et al., 2012; Wu et al., 2015). In 2015, Wu
et al. observed a significant association between prosociality
(mediated through emotional empathy) and AVPR1B in a
non-clinical Han Chinese male sample. Chakrabarti et al.
(2009) noted a nominally significant association between
AVPR1B and the empathy quotient (EQ) also in a non-clinical
sample.
OXTR, AVPR1A, and AVPR1B are genes that emerged
evolutionarily through duplication events and have both
paralogous and orthologous relationships in placental
mammals (Paré et al., 2016). Given their evolutionary
connections, roles in social behavior, and potential as
treatment target pathways in ASD, we investigated their
genetic variation within an ASD population. OXTR,
AVPR1A, and AVPR1B SNPs or microsatellites were
genotyped in ∼200 families and analyzed using family based
association testing (FBAT). OXTR and AVPR1A genetic
associations have been investigated in ASD previously,
but to our knowledge AVPR1B variants have not been
studied.
MATERIALS AND METHODS
Subjects were recruited through the Developmental Disorders
Clinic of the University of Illinois at Chicago (UIC) Institute
for Juvenile Research, referral from providers of autism services,
a website providing information about the study, and parent
advocacy organizations with the approval of the UIC Institutional
Review Board [IRB#: 2007-0239; Title: Interdisciplinary Studies
of Insistence on Sameness (IS) in Autism Spectrum Disorders
(ASD)]. All participants were provided with a description of the
study to obtain informed written consent from adults able to
consent for themselves, and parents or guardians of minors and
individuals unable to consent prior to their first session.
Participants
For each participant, a medical history and physical examination
were performed by a pediatric neurologist or child psychiatrist
and psychiatric evaluation by a child psychiatrist experienced in
ASD. Participants were diagnosed using the Autism Diagnostic
Observation Schedule (ADOS; Lord et al., 1999; Gotham et al.,
2007), Autism Diagnostic Interview-Revised (ADI-R; Rutter
et al., 2003; Risi et al., 2006), and confirmed by a physician
according to the DSM-IV-TR (American Psychiatric Association,
2000) ASD classification (including autism, Asperger disorder, or
pervasive developmental disorder-not otherwise specified (PDD-
NOS)). While subjects were not diagnosed with comorbidities,
individuals were selected to enrich the IS traits of the sample,
which may have increased the probability of comorbidity
with certain traits and disorders (i.e., OCD, high anxiety).
Additionally, individuals on psychotropic medications were
excluded. We performed SNP and microsatellite analysis on
two nearly identical samples (Table 1). Two hundred and seven
probands including 156 trios and 51 single parent-child duo
families were genotyped for SNP analysis. The microsatellite
sample consisted of 210 probands of which 206 probands
overlapped with the SNP sample (Table 1).
Instruments and Assessments
The instruments utilized to assess clinical presentation, including
social abilities and RRBs, were appropriate for the subjects’ ages
and abilities.
Autism Diagnostic Observation Schedule (ADOS): The
ADOS is a standardized, interactive, semi-structured assessment
administered by a trained professional resulting in a standardized
score that encompasses social interaction, communication, and
restricted interests and repetitive behaviors. The Social Affect
domain evaluates communication and reciprocal social
interaction including behaviors such as: unusual eye contact,
quality of social overtures, initiation of joint attention, amount
of facial expression directed at others, and frequency of
spontaneous vocalization directed to others gestures (Hus et al.,
2014; Hus Bal and Lord, 2015).
Autism Diagnostic Interview-Revised (ADI-R): The ADI-R is
a structured interview between a trained professional and
the parent or guardian of the individual. The assessment
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TABLE 1 | Demographic description of the probands analyzed.
SNP analysis MS Analysis
Number of participants 207 210
Average age (years) 9.89 (±5.48 SD) 10.23 (±6.25 SD)
Gender M: 170 (82.1%) M: 173 (82.4%)
F: 37 (17.9%) F: 37 (17.6%)
Race N = 207 N = 208
Caucasian/Western
European
154 (74.4%) 155 (73.8%)
African American/African 35 (16.9%) 35 (16.7%)
Asian 8 (3.9%) 8 (3.8%)
More than one race 10 (4.8%) 10 (4.8%)
IQ
FSIQ 79.93 (±24.03 SD;
N = 193)
80.70 (±24.49 SD; N = 194)
VIQ 77.50 (±26.01 SD;
N=196)
78.41 (±26.64 SD; N = 197)
NVIQ 82.12 (±23.86 SD;
N = 204)
82.63 (±24.12 SD; N = 205)
Demographic data describing the probands utilized for SNP and microsatellite (MS)
analyses. The two samples overlap, 206 probands are in both the SNP and microsatellite
analyses.
measures behaviors that include reciprocal social interaction,
communication and language, and patterns of behaviors. The
Insistence upon Sameness domain is comprised of three ADI-
R items: (1) compulsions and rituals, (2) resistance to changes
in personal routine, and (3) resistance to change in environment
(Hus et al., 2007).
Repetitive Behavior Scale-Revised (RBSR): The RBSR assesses
the presence, characterization, and severity of RRBs in
individuals with developmental disorders (Bodfish et al., 2000).
It is a 43-item form that categorizes RRBs into five factors—
compulsive behaviors, ritualistic and sameness behaviors,
restricted interests, stereotyped behaviors, and self-injurious
behaviors (Lam and Aman, 2007).
Aberrant Behavior Checklist—Community Version (ABC-CV):
The ABC-CV (Aman et al., 1985) is a five-factor, 53-item
questionnaire completed by the parent or guardian. The
ABC assesses symptoms of irritability and agitation, social
withdrawal (lethargy), stereotypic behavior, hyperactivity and
non-compliance, and inappropriate speech in individuals aged
6–54 years.
Genotyping
SNPs
We selected two AVPR1B and 13 OXTR SNPs to genotype based
on the literature. DNA was extracted from 10 mL of blood using
PureGene R© DNA Purification Kit. Next, DNA was quantified
with Quant-iTTM PicoGreen R© dsDNA Assay (Invitrogen,
Carlbad, CA) and the samples normalized to 10 ng/mL.
TaqMan R© SNP genotyping assays (Applied BiosystemsTM, Foster
City, CA) were then utilized to perform blinded genotyping
of the samples. Standard TaqMan R© SNP genotyping protocols
were used. TaqMan R© PCR reactions were performed in 5–
2.50 µL Universal Master Mix Amperase R© UNG, 0.125 µL
TaqMan R© probe mix, and 2.375 µL water. PCR conditions
(Applied BiosystemsTM GeneAmp R© PCR System 9700; Foster
City, CA) were: OneAmpErase R© step at 50.0◦C for 2 min, one
enzyme activation step at 95.0◦C for 10min, 40–99 alternating
cycles of denaturation at 92.0◦C for 15 s, and annealing and
extension at 58.0◦C for 1min. We used a Roche Light Cycler
Model 480-II and Roche Light Cycler 480 Gene Scanning
Software v.1.5 (Hoffmann–La Roche AG, Basel, Switzerland) to
measure fluorescence intensity of each allele of the final PCR
product.
Microsatellites
Utilizing primers and protocols from Kim et al. (2002), we
genotyped probands, mothers, and fathers blinded to the affect
status, family relationship, and demographic data. To summarize,
the protocol consisted of multiplex PCR reactions containing
50 ng of DNA, 200 _M dNTPs, 2.5 mM MgCl2, and 0.3 units of
AmpliTaq Gold DNA Polymerase (Applied BiosystemsTM, Foster
City, CA) in a 10 µl volume. Microsatellite peaks were measured
on the Applied Biosystems 3730xl and sized with Genemapper
3.7 (Applied BiosystemsTM, Foster City, CA, USA).
Analysis
Prior to analyzing the SNP data, we checked for genetic
Mendelian errors and Hardy-Weinberg equilibrium. Utilizing
PLINK v1.07 (Purcell et al., 2007), all but two SNPs were in
Hardy-Weinberg equilibrium (p-values > 0.05) in the overall
sample (note rs237851 and rs2268493: p < 0.05 in all parents).
Mendelian errors were rare and excluded from analysis on a per
SNP basis (the most Mendelian errors were observed in OXTR
rs11720238 with a total of three). We tested for associations
between OXTR and AVPR1B SNPs, ASD diagnosis, and scores
from assessments of social behavior and RRBs. Tests were carried
out using FBAT v2.0.3 (Laird et al., 2000; Rabinowitz and Laird,
2000). FBAT is a non-parametic test of linkage or association
between the genotype and the phenotype in which the covariance
between the phenotype and offspring genotype is estimated. Tests
were conducted assuming an additive inheritance model. Three
OXTR SNPs (rs53576, rs2254298, and rs2268493) were selected
based upon their previous associations with ASD in the literature
for haplotype analysis (bi-allelic mode; additive inheritance
model). We tested the three marker haplotype and the two
marker permutations. The nucleotide repeats of AVPR1A were
analyzed using a similarmethodology. Using FBAT,microsatellite
data were checked for Mendelian errors. Mendelian errors were
excluded from analysis on a permarker (RS1 and RS3) basis. Next
using an additive inheritance model, we used FBAT to examine
associations between the genetic variants of AVPR1A and ASD
diagnosis and other related phenotypes.
RESULTS
The relationships between genetic variations in the receptor
genes of OT and AVP, and ASD diagnosis and ASD-related
phenotypes were examined in our analysis. AVPR1B SNPs,
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rs35369693 (p = 0.025) and rs28632197 (p = 0.006), were
associated with ASD diagnosis and remained significant after
correction for multiple comparisons for SNPs tested in AVPR1B
(Table 2A). Next, we explored possible relationships with
ASD-related phenotypes. No further associations were noted
with AVPR1B SNPs (p-values were p > 0.100 for social
communication and restrictive/repetitive subphenotype scores).
OXTR rs2268493 (p = 0.050) was associated with ASD
diagnosis, but did not remain significant after multiple
comparison correction for the number of OXTR SNPs that
were tested. We also examined ASD-related subphenotypes
and found associations with Several OXTR SNPs (Table 2B).
rs2268493 was not only associated with ASD diagnosis, but
with measures of social behaviors as well as RRBs (ABC-Social
Withdrawal: p = 0.013; ADI-R IS as a restricted behavior:
p = 0.039). Similarly, rs4686302 was another SNP found to be
significantly associated with both subphenotype categories within
ASD (ABC-Social Withdrawal: p = 0.036; ABC-Stereotypy:
p = 0.018). We also found rs2254298 to be significantly
associated with ADOS-Social Affect (p = 0.023). No further
associations were noted for the remaining OXTR SNPs and
the characterized subphenotypes (p-values were p > 0.054).
None of the subphenotype associations were significant after
correcting for multiple comparisons. Additionally, we performed
a haplotype analysis utilizing FBAT. Both rs53576 and rs2254298
have been actively studied variants in the ASD literature (Wu
et al., 2005; Jacob et al., 2007; Lerer et al., 2008; Liu et al., 2010;
Wermter et al., 2010; Campbell et al., 2011; Di Napoli et al.,
2014), therefore, they were used along with rs2268493 to create
our haplotype. Haplotype analysis yielded significant associations
with ASD diagnosis and both ASD-related phenotypes (Table 3).
The two marker haplotype rs2254298–rs2268493 (A-T: p =
0.026) was significantly associated with ASD diagnosis. This same
haplotype was significantly associated with social behaviors as
measured by ADOS (Social Affect: p = 0.016) and ABC (Social
Withdrawal: p= 0.036). Overall, haplotypes were associated with
ASD diagnosis, RRBs as assessed by ADOS, and social behaviors
measured by ADOS and ABC.
FBAT was also utilized to examine relationships between
microsatellites in AVPR1A, ASD, and subphenotypes. No main
effects were noted; however, significant associations were
observed with assessments measuring RRBs. Length variants in
both RS1 and RS3 were found to be significantly associated
with different measures of RRBs (Table 4A). Some studies have
categorized the variant lengths as short (S) and long (L) due
to the variation of defining lengths across studies (i.e., RS1 306
was analogous to RS1 308 and RS1 312 in different studies—
see Table 2 in Kantojärvi et al., 2015). While we analyzed the
microsatellite data using individual lengths, afterwards for ease
of comparison with other published studies we categorized the
length variant values as S or L. The cutoff was determined by
creating two approximately equal groups (Knafo et al., 2008).
The split occurred between the highest and second highest
frequencies reported in our sample (Table 4B). Utilizing S/L
categories, we noted long variants of RS1 and RS3 were associated
with different measures of RRBs in our sample. We found a
significant association with a short length variant (RS1 S) and
RRBs as measured by the RBSR.
DISCUSSION
The core symptoms of ASD include impairments in social
communication and the presence of RRBs. Given the well-
established links between the OT/AVP system and these
behaviors, genetic variants and associations were investigated in
this ASD sample.We used FBAT to examine associations between
receptor genes of these neuropeptides and ASD. The variants
in AVPR1B (SNPs—rs35369693 and rs28632197), AVPR1A (two
microsatellites—RS1 and RS3), and OXTR (13 SNPs) were
TABLE 2 | Significant SNP associations.
A
SNP p-value Z Risk Allele
AVPR1B rs35369693* 0.025 2.24 G
AVPR1B rs28632197* 0.006 2.77 A
OXTR rs2268493 0.050 1.96 T
B
Phenotype SNP p-value Z Allele Risk Allele
Social communications ABC—Social withdrawal OXTR rs4686302 0.036 –2.09 T C
OXTR rs2268493 0.013 –2.49 C T
ADOS—Social affect OXTR rs2254298 0.023 2.27 A A
Restricted/Repetitive behaviors ABC—Stereotypy OXTR rs4686302 0.018 2.37 C C
ADOS—RRB OXTR rs1042778 0.011 –2.54 T G
ADI—IS OXTR rs2268493 0.039 –2.07 C T
(A) list the SNPs in both OXTR and AVPR1B that were found to be significantly associated with ASD diagnosis. (B) notes the SNP significantly associated with ASD-related phenotypes,
mainly social communications and RRBs, in our sample using the additive inheritance model. None of the AVPR1B SNPs were significantly associated with the different subphenotypes
(p > 0.100). The remaining OXTR SNPs were also not significantly associated with the subphenotypes (p > 0.054). * denotes significant after correcting for multiple comparisons.
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TABLE 3 | Haplotype analysis using three markers from OXTR.
Phenotype Markers Haplotype p-value Z
ASD rs2254298 rs2268493 A T 0.026 2.23
ADOS−-Social affect rs53576 rs2254298 rs2268493 G A T 0.008 2.63
rs53576 rs2254298 G A 0.017 2.40
rs2254298 rs2268493 A T 0.016 2.41
ABC−-Social withdrawal rs53576 rs2254298 rs2268493 G G C 0.009 −2.59
rs53576 rs2268493 G C 0.009 −2.62
rs2254298 rs2268493 A T 0.036 2.10
ADOS−-RRB rs53576 rs2254298 rs2268493 A G C 0.032 −2.15
rs53576 rs2268493 A C 0.024 −2.25
Haplotypes were created from three SNPs (rs53576, rs2254298, and rs2268493) previously associated with ASD. Data were analyzed for associations with ASD diagnosis and
subphenotypes.
studied in association with ASD diagnosis, as well as scores from
assessments measuring deficits in social behaviors and RRBs.
To our knowledge, there are no published studies reporting
AVPR1B associations with ASD. Our results showed that both
AVPR1B SNPs, rs35369693, and rs28632197, were significantly
associated with ASD diagnosis (Table 2A). Variants within
AVPR1B have been linked to social behavior in humans and
other mammals. As mentioned earlier, Avpr1b−/− mice show
decreased aggression and altered dominance behavior (Caldwell
et al., 2010; Pagani et al., 2015). Human studies including
our results have linked AVPR1B to disorders with social
components including bipolar type I, depression, autistic traits
as measured by EQ, childhood aggression, COMD, suicidal
attempts, prosociality, and emotional empathy (Dempster et al.,
2007; Chakrabarti et al., 2009; Leszczynska-Rodziewicz et al.,
2012; Zai et al., 2012; Szczepankiewicz et al., 2013; Luppino
et al., 2014; Wu et al., 2015). Specifically, Zai et al. (2012) found
rs3536969C to be underrepresented in 177 aggressive child cases
as compared to adult matched controls. This finding remained
significant when a homogenous European Ancestry subsample
was analyzed. In a Hungarian sample (382 nuclear families),
Dempster et al. (2007) found rs35369693 to be significantly
associated with COMD. They also noted a sex difference:
when divided by sex, the association remained significant for
affected females. Additionally, associations between anxiety
and panic disorders and AVPR1B rs28632197 have been
observed (Keck et al., 2008). Keck and colleagues compared
individuals with panic disorder with matched controls and found
nominal associations with panic disorder andAVPR1B, including
rs28632197 (p = 0.046), in their main sample (not significant
in their replication sample or the combined sample). They
also examined interactions between AVPR1B and CRHR1 in
their samples. Two SNP pairs, AVPR1B rs28632197—CRHR1
rs878886 and AVPR1B rs28632197—CRHR1 rs187631, were also
found to be significantly associated with panic disorder. While
previous findings were not conducted in an ASD sample, anxiety,
aggression, and depression are often co-morbid issues along with
restrictive behaviors and social challenges in ASD (Giles and
Martini, 2016; Russell et al., 2016).
The OXTR SNP, rs2268493, was not only related to diagnosis,
but also with scales measuring impairments in social behaviors
and RRBs (Tables 2A,B). Both subphenotypes, social behaviors
and RRBs, are characteristic of ASD. While these findings
did not withstand correction for multiple comparisons, they
replicated similar findings in the literature. Yrigollen et al.
(2008) found rs2268493 to be significantly associated with
diagnosis, communication skills, and stereotyped behaviors.
Subsequently, Campbell et al. (2011) used a narrow diagnosis
of autism in an Autism Genetic Resource Exchange (AGRE)
sample and found rs2268493T to be significantly associated
with their diagnosis criteria. In schizophrenia, rs2268493T has
also been associated with social cognition (Davis et al., 2014).
Decreased activity in the mesolimbic reward circuitry during
reward anticipation in typically-developed adults was associated
with the T homozygotes of rs2268493 (Damiano et al., 2014).
Additionally, as part of a haplotype rs2268493 was associated
with Asperger Syndrome (Di Napoli et al., 2014).
Other significant associations were noted between variants
in OXTR and assessments of core characteristics of ASD in
the entire sample (Table 2B). Besides rs2268493, which was
associated with social behaviors and RRBs, rs4686302 had
significant associations across both categories of phenotypes.
rs4686302 has been associated with emotional empathy in a non-
clinical Chinese sample (Wu et al., 2012). Wu et al. (2012) found
the CC homozygotes to have less cognitive and trait empathy
than the CT heterozygotes in their sample. We found rs1042778
was significantly associated with RRBs as measured by ADOS.
This SNP (G-allele) has also been associated with ASD diagnosis
in an AGRE sample (Campbell et al., 2011) and creative cognition
in a non-patient Han Chinese sample (De Dreu et al., 2014). In
the study conducted by De Dreu et al. (2014), creativity gives
the individual the ability to adapt and be flexible to changing
circumstances and social situations.
A significant association was also observed between rs2254298
and ADOS-Social Affect. This SNP has been affiliated with social
impairment in two recent studies, Parker et al. (2014) found
rs2254298 to be associated with social impairment in an ASD and
typically developing sample. Also, in a meta-analysis conducted
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TABLE 4 | FBAT analysis for AVPR1A microsatellites and allelic
frequencies.
A
Marker Allele p-value Z
Restricted/Repetitive
behaviors
ABC–Stereotypy RS1 318 0.015 2.44
RS1 322 0.027 –2.21
ADOS–RRB RS3 344 0.003 2.93
RBSR–Compulsive and
Ritualistic/Sameness
subscale total
RS1 310 0.020 –2.32
RS3 336 0.014 –2.45
RBSR–Total RS1 310 0.047 –1.98
RS3 336 0.008 –2.65
RS3 338 0.042 –2.03
B
RS1 RS3
Allele Percent Allele Percent
306 0.005 317 0.012
310 0.100 326 0.003
314 0.387(S) 328 0.063
318 0.263(L) 330 0.104
322 0.106 332 0.236(S)
326 0.079 334 0.195(L)
330 0.023 336 0.130
334 0.032 338 0.110
338 0.006 340 0.041
342 0.001 342 0.015
344 0.046
346 0.029
348 0.015
350 0.002
353 0.001
(A) lists the significant associations with ASD-related phenotypes. (B) displays allelic
frequencies of AVPR1A in our sample. The bold text denotes the allele with the highest
frequency. The underlined text identifies the second highest allelic frequency for the
markers. This “border” is often used to delineate short (S) and long (L) allelic categories.
The categories are determined by creating approximately equal percentages in each
category (Knafo et al., 2008).
by LoParo and Waldman (2015) they found rs2254298 and two
other OXTR SNPs to be associated with ASD in analysis of eight
studies and 11 independent samples. In 2008, Lerer et al. found
rs2254298 to be associated with Vineland Adaptive Behavior
Scales-2nd Edition (VABS-II) and an active marker in their
haplotype analysis in a male ASD Israeli sample (Lerer et al.,
2008). Given these previous ASD findings and the relationship
between diagnosis and both categories of subphenotypes in
our sample, rs2254298 and rs2268493 in addition to rs53576
were used in our haplotype analysis. rs53576 has had previous
associations in ASD samples. rs53576 was found to be associated
with ASD, social behavior, and emotional withdrawal in a patient
population (Wu et al., 2005; Chang et al., 2014; Haram et al.,
2015). However, in this sample we did not find associations
with rs53576 as an individual SNP. The two marker haplotype,
rs2254298A–rs2268493T was found to be associated with ASD
diagnosis (Table 3).
In addition to SNPs, we studied the microsatellites located
in the 5′ flanking region of AVPR1A, RS1, and RS3, in
association with ASD-related phenotypes (Table 4A). Our
significant associations were observed with several measures of
RRBs. AVPR1A RS3 length variants that can be categorized as
L were associated with these assessments. While we did not
find associations with diagnosis or social behavior in the whole
sample, others have found affiliations in ASD samples (Kim
et al., 2002; Wassink et al., 2004; Yang et al., 2010b; Kantojärvi
et al., 2015). Associations between AVPR1A microsatellites and
social behaviors were also noted in both patient and non-patient
samples in several studies (Knafo et al., 2008; Ebstein et al., 2009;
Levin et al., 2009; Meyer-Lindenberg et al., 2009).
Future research should address the limitations of our study
along with the inconsistencies in the literature. Firstly, our
findings (SNPs, haplotypes, and microsatellites) need to be
replicated in a larger sample, particularly given the small effect
of specific inherited common variants in ASD based on genome-
wide association studies of ASD (Anney et al., 2012; Chaste
et al., 2015). A larger sample would also allow additional analysis
of other subgroups, such as sex differences. This is of interest,
because there are sex differences between the OT and AVP
systems and ASD is diagnosed in males more often than females
(Chakrabarti and Fombonne, 2005; Carter et al., 2008). Another
factor that can contribute to inconsistent results is the use
of differing diagnostic tools and criteria, especially because of
the heterogeneity of the disorder. Alternative tools in both
international and national studies could be measuring slightly
different aspects of behaviors. Lastly, varying methodologies can
be a contributing factor as well. In the analysis of microsatellites,
differing groups define the variant lengths differently (see Table 2
in Kantojärvi et al., 2015).
OT and AVP systems influence mammalian brain pathways
related to social and adaptive (vs. rigid, restricted) behaviors.
There is a growing literature about OT and AVP in a range of
disorders including schizophrenia, COMD, bipolar disorder as
well as neurodevelopmental disorders (Dempster et al., 2007;
Leszczynska-Rodziewicz et al., 2012; Davis et al., 2014; Francis
et al., 2014). There are currently many clinical trials exploring the
therapeutic value of OT and AVP (e.g., in ASD, schizophrenia,
major depressive disorder, and substance dependence). With
shifts from disorder-based to circuit-based therapeutic targets,
studies of OT and AVP genetics need to explore associations
with social and rigid behavior subphenotypes in larger samples.
Overall, our results suggest further research of the OT/AVP
system, including OXTR, AVPR1A, and especially AVPR1B in
ASD and other disorders with social impairment and/or RRBs.
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